Publicacions (55) Publicacions de Rafael Aldabe Arregui

2024

  1. Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice

    Viruses, Vol. 16, Núm. 3

  2. Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice

    PLoS ONE, Vol. 19, Núm. 5

  3. Multiscale and multimodal evaluation of autosomal dominant polycystic kidney disease development

    Communications Biology, Vol. 7, Núm. 1

  4. NatB Protects Procaspase-8 from UBR4-Mediated Degradation and Is Required for Full Induction of the Extrinsic Apoptosis Pathway

    Molecular and Cellular Biology, Vol. 44, Núm. 9, pp. 358-371

  5. Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice

    PLoS Pathogens, Vol. 20, Núm. 5

  6. The infectivity of AAV9 is influenced by the specific location and extent of chemically modified capsid residues

    Journal of Biological Engineering, Vol. 18, Núm. 1

2023

  1. NatB Catalytic Subunit Depletion Disrupts DNA Replication Initiation Leading to Senescence in MEFs

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

2022

  1. Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2021

  1. Aav-hdv: An attractive platform for the in vivo study of hdv biology and the mechanism of disease pathogenesis

    Viruses, Vol. 13, Núm. 5

  2. Consequences of Mammalian Target of Rapamycin Inhibition on Adeno-Associated Virus Hepatic Transduction Efficacy

    Human Gene Therapy, Vol. 32, Núm. 19-20, pp. 1242-1250

  3. Novel vectors and approaches for gene therapy in liver diseases

    JHEP Reports, Vol. 3, Núm. 4

  4. Oligonucleotide-based therapies for renal diseases

    Biomedicines, Vol. 9, Núm. 3

  5. Use of an adeno-associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model

    Journal of Inherited Metabolic Disease, Vol. 44, Núm. 6, pp. 1369-1381

2020

  1. Maturation of NAA20 Aminoterminal End Is Essential to Assemble NatB N-Terminal Acetyltransferase Complex

    Journal of Molecular Biology, Vol. 432, Núm. 22, pp. 5889-5901

  2. N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity

    Neurobiology of Disease, Vol. 137

  3. TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection

    JHEP Reports, Vol. 2, Núm. 3

2018

  1. Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679] (S0168827817320469) (10.1016/j.jhep.2017.05.010))

    Journal of Hepatology

  2. N-terminal acetylation modulates Bax targeting to mitochondria

    International Journal of Biochemistry and Cell Biology, Vol. 95, pp. 35-42

2017

  1. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction

    Journal of Hepatology, Vol. 67, Núm. 4, pp. 669-679

  2. NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma

    Oncotarget, Vol. 8, Núm. 25, pp. 40967-40981